Utilization of chinese hamster cells in vitro and in vivo in genetic toxicology: A multiphasic approach

An approach often used to study genetic risk is comparative mutagenesis in different organisms. We have begun the development and validation of a multiphasic genetic toxicity system using the Chinese hamster and its somatic cells to measure mutational events in the same (or similar) gene, the same chromosome derived from the same animal (Fig. 1). This system will eliminate much of the uncertainty generated when different mutational events in such evolutionally divergent organisms as bacteria, insects, and mammals are compared. Using CHO cells we have defined an assay, CHO/HGPRT, to determine mutation at the hgprt locus. Coupled with S9 metabolic activation system, the CHO/HGPRT assay can quantify gene mutation and cytotoxicity induced by various classes of chemicals, physical agents, and the combination thereof. The quantitative nature of this assay permits elucidation of the structure-activity relationship for a given class of direct-acting agents. By incorporating the cytogenetics of CHO cells into this assay we can simultaneously measure induced chromosome aberrations and SCE. Using the stable CHO/human hybrid cell line AL-J1 measurement of chromosome deletion and/loss can be also performed. In order to further expand the usefulness of this genetic toxicity system to the molecular and whole animal levels we have begun development and validation of two additional systems. To study the molecular events which may result in mutation we are developing a CHOpSVgpt system. A Chinese hamster system with treatment in vivo is being developed to study mutation at the hgprt locus, chromosome aberration, and SCE in spleen cells in vitro. The use of this multiphasic genetic toxicity system at the cellular, molecular, and animal levels may soon provide reliable and rapid identification of suspected environmental mutagens.